Contraception and Mental Health: a Commentary on the Evidence and Principles for Practice

Overview

Journal Am J Obstet Gynecol

Publisher Elsevier

Specialty Gynecology & Obstetrics

Date 2014 Dec 17

PMID 25511241

Citations 22

Authors

Kelli Stidham Hall

Julia R Steinberg

Carrie A Cwiak

Rebecca H Allen

Sheila M Marcus

Affiliations

Soon will be listed here.

Abstract

Among the most prevalent and disabling chronic diseases affecting reproductive-aged women worldwide, depression and anxiety can contribute to adverse reproductive health outcomes, including an increased risk of unintended pregnancy and its health and social consequences. For women with these common mental health conditions who want to avoid an unintended pregnancy, effective contraception can be an important strategy to maintain and even improve health and well-being. Reproductive health clinicians play a critical role in providing and managing contraception to help women with mental health considerations achieve their desired fertility. In this commentary, we review the literature on relationships between mental health and contraception and describe considerations for the clinical management of contraception among women with depression and anxiety. We discuss issues related to contraceptive method effectiveness and adherence concerns, mental health-specific contraceptive method safety and drug interaction considerations, and clinical counseling and management strategies. Given important gaps in current scientific knowledge of mental health and contraception, we highlight areas for future research.

Citing Articles

Pharmacovigilance study of the association between progestogen and depression based on the FDA adverse event reporting System (FAERS).

Gao H, Zhai X, Hu Y, Wu H Sci Rep. 2025; 15(1):1302.

PMID: 39779872 PMC: 11711629. DOI: 10.1038/s41598-025-85826-1.

Association of perinatal depression and postpartum contraception intent, choice, and actual use.

Masters G, Julce C, Carroll S, Person S, Allison J, Byatt N Contraception. 2024; 135:110447.

PMID: 38583583 PMC: 11323034. DOI: 10.1016/j.contraception.2024.110447.

Development of an Implementation Blueprint to Scale-Up Contraception Care for Adolescents with Psychiatric Conditions in a Pediatric Hospital.

Hyzak K, Bunger A, Herrmann S, Kerlek A, Lauden S, Dudley S Glob Implement Res Appl. 2024; 3(2):147-161.

PMID: 38293653 PMC: 10827339. DOI: 10.1007/s43477-023-00082-7.

Testosterone and Prolactin Perturbations Possibly Associated with Reduced Levels of β-Arrestin1 in Mononuclear Leukocytes of Women with Premenstrual Dysphoric Disorder.

Nayyar S, Archibong A, Nayyar T Int J Mol Sci. 2023; 24(20).

PMID: 37895130 PMC: 10607656. DOI: 10.3390/ijms242015449.

Contraception use and satisfaction among mothers with low income: Evidence from the Baby's First Years study.

Costanzo M, Magnuson K, Gennetian L, Halpern-Meekin S, Noble K, Yoshikawa H Contraception. 2023; 129:110297.

PMID: 37806470 PMC: 10843149. DOI: 10.1016/j.contraception.2023.110297.

References

DiMatteo M, Lepper H, Croghan T . Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000; 160(14):2101-7. DOI: 10.1001/archinte.160.14.2101. View

Robinson S, Dowell M, Pedulla D, McCauley L . Do the emotional side-effects of hormonal contraceptives come from pharmacologic or psychological mechanisms?. Med Hypotheses. 2004; 63(2):268-73. DOI: 10.1016/j.mehy.2004.02.013. View

Murphy P, Kern S, Stanczyk F, Westhoff C . Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception. 2005; 71(6):402-8. DOI: 10.1016/j.contraception.2004.11.004. View

Edelman A, Gallo M, Jensen J, Nichols M, Schulz K, Grimes D . Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2005; (3):CD004695. DOI: 10.1002/14651858.CD004695.pub2. View

Mann J . The medical management of depression. N Engl J Med. 2005; 353(17):1819-34. DOI: 10.1056/NEJMra050730. View

Finer L, Henshaw S . Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006; 38(2):90-6. DOI: 10.1363/psrh.38.090.06. View

Lehrer J, Shrier L, Gortmaker S, Buka S . Depressive symptoms as a longitudinal predictor of sexual risk behaviors among US middle and high school students. Pediatrics. 2006; 118(1):189-200. DOI: 10.1542/peds.2005-1320. View

OConnell K, Davis A, Kerns J . Oral contraceptives: side effects and depression in adolescent girls. Contraception. 2007; 75(4):299-304. DOI: 10.1016/j.contraception.2006.09.008. View

Alder J, Fink N, Bitzer J, Hosli I, Holzgreve W . Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med. 2007; 20(3):189-209. DOI: 10.1080/14767050701209560. View

10.

Moreau C, Trussell J, Gilbert F, Bajos N, Bouyer J . Oral contraceptive tolerance: does the type of pill matter?. Obstet Gynecol. 2007; 109(6):1277-85. DOI: 10.1097/01.AOG.0000260956.61835.6d. View

11.

Lopez L, Tolley E, Grimes D, Chen-Mok M . Theory-based strategies for improving contraceptive use: a systematic review. Contraception. 2009; 79(6):411-7. DOI: 10.1016/j.contraception.2008.12.006. View

12.

Hackley B, Sharma C, Kedzior A, Sreenivasan S . Managing mental health conditions in primary care settings. J Midwifery Womens Health. 2010; 55(1):9-19. DOI: 10.1016/j.jmwh.2009.06.004. View

13.

Miller E, Decker M, McCauley H, Tancredi D, Levenson R, Waldman J . Pregnancy coercion, intimate partner violence and unintended pregnancy. Contraception. 2010; 81(4):316-22. PMC: 2896047. DOI: 10.1016/j.contraception.2009.12.004. View

14.

Gallo M, Nanda K, Grimes D, Lopez L, Schulz K . 20 µg versus >20 µg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2011; (1):CD003989. DOI: 10.1002/14651858.CD003989.pub4. View

15.

Lawrie T, Helmerhorst F, Maitra N, Kulier R, Bloemenkamp K, Gulmezoglu A . Types of progestogens in combined oral contraception: effectiveness and side-effects. Cochrane Database Syst Rev. 2011; (5):CD004861. DOI: 10.1002/14651858.CD004861.pub2. View

16.

Farr S, Dietz P, Williams J, Gibbs F, Tregear S . Depression screening and treatment among nonpregnant women of reproductive age in the United States, 1990-2010. Prev Chronic Dis. 2011; 8(6):A122. PMC: 3221564. View

17.

van Vliet H, Grimes D, Lopez L, Schulz K, Helmerhorst F . Triphasic versus monophasic oral contraceptives for contraception. Cochrane Database Syst Rev. 2011; (11):CD003553. PMC: 7154342. DOI: 10.1002/14651858.CD003553.pub3. View

18.

. ACOG Committee Opinion No. 518: Intimate partner violence. Obstet Gynecol. 2012; 119(2 Pt 1):412-7. DOI: 10.1097/AOG.0b013e318249ff74. View

19.

Steinberg J, Trussell J, Hall K, Guthrie K . Fatal flaws in a recent meta-analysis on abortion and mental health. Contraception. 2012; 86(5):430-7. PMC: 3646711. DOI: 10.1016/j.contraception.2012.03.012. View

20.

Frost J, Lindberg L, Finer L . Young adults' contraceptive knowledge, norms and attitudes: associations with risk of unintended pregnancy. Perspect Sex Reprod Health. 2012; 44(2):107-16. DOI: 10.1363/4410712. View